Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...
Whereas the GOLD 2022 report noted the efficacy of LABA+ICS in patients with moderate to very severe COPD and exacerbations, the GOLD 2023 and 2024 reports underscore, “Use of LABA+ICS in COPD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback